安进生物ANJIN品牌怎么样 申请店铺

我要投票 安进生物ANJIN在兽药行业中的票数:420 更新时间:2025-08-25
安进生物ANJIN是哪个国家的品牌?「安进生物ANJIN」是 河南安进生物技术股份有限公司 旗下著名品牌。该品牌发源于河南省新乡市,由创始人岳 * 光在2009年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力安进生物ANJIN品牌出海!将品牌入驻外推网,定制安进生物ANJIN品牌推广信息,可以显著提高安进生物ANJIN产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

安进生物ANJIN怎么样

河南安进生物技术股份有限公司是一家以兽药、水产药研发、生产、销售为一体的大型现代化、高科技企业集团,现公司产品已覆盖兽药、水产药、饲料、饲料添加剂等动物保健品领域。

河南安进生物技术股份有限公司原GMP生产基地位于风景秀丽的郑州唐庄工业区,于2008年组建后一次性顺利通过国家农业部GMP专家组验收,2010年为扩大生产规模,在新乡市平原新区投资建立新厂,现拥有粉剂/散剂/预混剂、灭菌小容量注射剂(含中药提取)/灭菌大容量非静脉注射剂(含中药提取)/口服溶液剂(含中药提取)、粉针剂、消毒剂(液体)/杀虫剂(液体)等标准GMP车间及现代化实验室,2011年1月一次性以优异的成绩顺利通过农业部GMP专家组验收,一致认可为合格GMP生产线。

为进一步完善公司产品结构正规化、品牌化和科学化,公司倾巨资引进水质改良剂,水底净化剂生产线,优良的中药提取设备、检测设备和现代化生产技术工艺以及高标准的质量认证体系,结合目前中国地区养殖业发展现状,使产品更适合现阶段养殖动物机体应用。

人才是企业的生存之本、发展之源。因此安进把广揽人才做为头等大事来抓。几年来先后引进产品研发、市场营销、运营管理等各类人才100余人,在企业经营中发挥了具大的作用,也为公司的长远发展打下了坚实的基础。此外,还与多所院校有合作关系,依托高校、产研院所的技术优势,推动公司各项经营活动发展。

当前,安进人正以“打造农牧养殖服务业企业”为目标,在“诚信、创新、超越”的企业精神指引下,秉承“市场是根、质量是命”的经营理念,一手抓产品研发,一手抓市场营销,力争在不远的将来,安进必将成为国内动物保健品领域较具竞争优势的企业之一。


Henan Anjin Biotechnology Co., Ltd. is a large-scale modern and high-tech enterprise group integrating the R & D, production and sales of veterinary drugs and aquatic drugs. Its products now cover the fields of veterinary drugs, aquatic drugs, feed, feed additives and other animal health products. The former GMP production base of Henan amjin Biotechnology Co., Ltd. is located in the beautiful Tangzhuang industrial zone of Zhengzhou. It was successfully accepted by the GMP expert group of the Ministry of agriculture of the people's Republic of China after its establishment in 2008. In 2010, in order to expand the production scale, it invested in the establishment of a new factory in Pingyuan new area of Xinxiang City. Now it has powder / powder / premix, small volume sterile injection (including extraction of traditional Chinese Medicine) / large sterilization Standard GMP workshops and modern laboratories, such as volume non intravenous injection (including extraction of traditional Chinese Medicine) / oral solution (including extraction of traditional Chinese Medicine), powder injection, disinfectant (liquid) / insecticide (liquid), etc., passed the acceptance of GMP expert group of Ministry of agriculture in January 2011 with excellent performance and were unanimously recognized as qualified GMP production line. In order to further improve the standardization, branding and scientificalness of the company's product structure, the company has invested heavily in the introduction of water quality improver, underwater purification agent production line, excellent Chinese medicine extraction equipment, testing equipment, modern production technology and high standard quality certification system, combined with the current development of the aquaculture industry in China, so that the products are more suitable for the application of animal body at the present stage 。 Talents are the foundation of survival and the source of development of enterprises. As a result, Amgen has made recruiting talents a top priority. Over the past few years, more than 100 talents have been introduced, including product research and development, marketing, operation and management, which have played an important role in the business operation and laid a solid foundation for the long-term development of the company. In addition, it also has cooperative relations with many colleges and universities, relying on the technical advantages of colleges and universities, production and research institutes, to promote the development of various business activities of the company. At present, Amgen is aiming at "building an agricultural and animal husbandry service enterprise", under the guidance of the enterprise spirit of "integrity, innovation and Transcendence", adhering to the business philosophy of "market is the root, quality is the life", focusing on product research and development, marketing, and striving to become one of the enterprises with competitive advantages in the field of domestic animal health products in the near future.

本文链接: https://brand.waitui.com/b975cd125.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

格林美:筹划发行H股股票并在香港联交所上市

36氪获悉,格林美发布公告,经充分研究论证,董事会同意公司发行H股股票并在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。公司将充分考虑现有股东的利益和境内外资本市场的情况,在股东会决议有效期内(即经公司股东会审议通过之日起24个月或同意延长的其他期限)选择适当的时机和发行窗口完成本次发行上市。截至目前,公司正积极与相关中介机构就本次发行上市的相关工作进行商讨,除本次董事会、监事会审议通过的相关议案外,其他关于本次发行上市的具体细节尚未最终确定。

9分钟前

中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元

36氪获悉,中信证券研报表示,创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求,改变前列腺癌诊疗范式,实现诊疗一体化,提高患者依从性和生存期。目前中国尚无任何RDC上市,市场呈现蓝海状态,海外前列腺癌RDC诊疗产品在2021年上市,2024年市场已接近30亿美元,充分验证了其巨大的商业价值。中信证券认为中国有望复刻海外前列腺癌RDC诊疗市场发展路径,预计未来中国前列腺癌RDC诊疗市场将超100亿元,市场呈现高速增长状态。该行业关键点为核素、配体分子形态、生产配送能力,建议关注在上述条件具有优势的公司。

9分钟前

​锡业股份:上半年净利润10.62亿元,同比增长32.76%

36氪获悉,锡业股份披露2025年半年报,上半年实现营业收入210.93亿元,同比增长12.35%;归属于上市公司股东的净利润10.62亿元,同比增长32.76%;基本每股收益0.626元。

9分钟前

亚世光电:上半年净利润538.04万元,同比下降36.21%

36氪获悉,亚世光电披露2025年半年报,上半年实现营业收入4.32亿元,同比增长30.01%;归属于上市公司股东的净利润538.04万元,同比下降36.21%;基本每股收益0.0331元。

9分钟前

金螳螂:上半年净利润3.58亿元,同比增长3.95%

36氪获悉,金螳螂披露2025年半年报,上半年实现营业收入95.28亿元,同比增长2.49%;归属于上市公司股东的净利润3.58亿元,同比增长3.95%;基本每股收益0.1348元。

9分钟前

本页详细列出关于安进生物ANJIN的品牌信息,含品牌所属公司介绍,安进生物ANJIN所处行业的品牌地位及优势。
咨询